Colibri Heart Valve LLC (Colibri Heart Valve) is a privately held medical device company that researches and develops novel, patent-protected, and structural heart technologies. The company’s products include Colibri transcatheter aortic valve implantation system, pipeline products and clinical development products. It also develops a pre-mounted, pre-crimped, pre-loaded and ready-for-use balloon-expandable transcatheter aortic valve implantation system through its proprietary tissue technology and valve design. Colibri Heart Valve develops disruptive next-generation structural heart technologies that address patient and healthcare market needs, research and develops dry tissue, heart valve design and delivery system technology among others. The company provides its products through its agents, brokers and distributors located across the US. Colibri Heart Valve is headquartered in Broomfield, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Colibri Heart Valve LLC
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Venibri Transcatheter Heart Valve System Product Overview
Colibri Heart Valve LLC - Key Competitors
Colibri Heart Valve LLC - Key Employees
Colibri Heart Valve LLC - Locations And Subsidiaries
Head Office
Recent Developments
Colibri Heart Valve LLC, Recent Developments
Dec 04, 2023: Colibri’s valve shows superior haemodynamics in pilot study
Nov 03, 2021: Colibri Heart Valve Initiates International CE Mark-enabling Pilot Study of Second-Generation TAVI System
Sep 24, 2019: Colibri Heart Valve receives a United States patent directed to a replacement heart valve that includes a dry valve sutured to a stent member
May 14, 2019: Colibri Heart Valve to present one-year patient follow-up results from clinical feasibility study of Second-Generation TAVI System at EuroPCR
Sep 19, 2018: Colibri Heart Valve to present patient follow-up results from clinical feasibility study of second-generation TAVI System at TCT
May 04, 2018: Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
Mar 19, 2018: Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
Mar 03, 2017: Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification
Oct 27, 2016: The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive Dry Tissue Technology Conducted
Apr 27, 2016: Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter
Table 11: Colibri TAVI System - Product Description
Table 12: Colibri TAVI System - A Prospective, Single Arm Clinical Investigation Evaluating Safety and Performance of the Colibri Transcatheter Aortic Heart Valve System for the Treatment of Symptomatic Severe Aortic Stenosis Via Transfemoral Access in High Surgical Risk Patients
Table 13: Custom Delivery System - Product Status
Table 14: Custom Delivery System - Product Description
Table 15: Delta Aortic Heart Valve - Product Status